The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis

Authors
Category Primary study
JournalHEALTH TECHNOLOGY ASSESSMENT
Year 2005
This article has no abstract
Epistemonikos ID: e1ac7c7cb41f0b063fb91c39db9a70e3a02d5387
First added on: Nov 14, 2025